Features
Understanding Optical Coherence Tomography Angiography in Glaucoma
Parsing the data can benefit patients.
By Karanjit S. Kooner, MD, PhD
Ab-Interno Canaloplasty to Modify Pathology in Glaucoma
A less invasive canaloplasty could be simpler and safer for patients.
By Mark J. Gallardo, MD
Evaluating Contrast Sensitivity in Visual Function
Are we ignoring a crucial element of vision?
By Jesse Richman, MD, George Spaeth, MD, Eric Spaeth
Incorporating New Glaucoma Drugs Into Practice
Entrants to the field change the treatment paradigm.
By Inder Paul Singh, MD
Risk Management Issues in Glaucoma
Examining risk in diagnosis and treatment.
By Steven V.L. Brown, MD, FACS, Ryan Bucsi, Nicole Kesten, MS
WEB EXCLUSIVE: Continuity of Care for Glaucoma Patients
Ensuring the best care for patients who travel often.
By STANLEY J. BERKE, MD, FACS, Paul N. Schacknow, MD, PhD
Web Exclusives
UK Study: SLT Should Be First-Line Treatment
By Jerry Helzner, contributing editor
FDA Approves Aerie’s Rocklatan IOP-Lowering Combination
By Jerry Helzner, contributing editor
Two Types of Tonometer Vary in IOP Readings
By Jerry Helzner, contributing editor
Hybrid MIGS Procedure Proves Effective
By Jerry Helzner, contributing editor
Sight Sciences’ TRAB360 Effective in Single-Center Study
By Jerry Helzner, contributing editor
iStent Trials Show Effectiveness at 5 Years
By Jerry Helzner, contributing editor
Ivantis Reports 3-Year Data for Hydrus Microstent
By Jerry Helzner, contributing editor
Bimatoprost SR Durability Excels in Early Trial
By Jerry Helzner, contributing editor
Rhopressa Effective in “Real-World” Study
By Jerry Helzner, contributing editor
Simplified Trabeculectomy Shows Fewer Complications
By Jerry Helzner, contributing editor
Pivotal iStent Inject Data Led to Approval
By Jerry Helzner, contributing editor
Virtual Reality May Help in Glaucoma Detection
By Jerry Helzner, contributing editor
Glaukos to Distribute Santen Glaucoma Device
By Jerry Helzner, contributing editor
Microdose Latanoprost Delivery Set for Broad Patient Base
By Jerry Helzner, contributing editor
Ivantis Reports 2-Year Hydrus Trial Data
By Jerry Helzner, contributing editor
Artificial Intelligence Holds Promise for Earlier Glaucoma Detection
By Jerry Helzner, contributing editor
Statin Use May Reduce Glaucoma Risk
By Jerry Helzner, contributing editor
Algorithm Captures Predictive Glaucoma Data
By Jerry Helzner, contributing editor
AGS Innovator Award Given to Mary G. Lynch, MD
By Jerry Helzner, contributing editor
Shaffer Prize for Innovative Glaucoma Research Awarded to Adriana Di Polo, PhD
By Jerry Helzner, contributing editor
Telemedicine Screening Effort Deemed a Success
By Jerry Helzner, contributing editor
Q BioMed Licenses Glaucoma Progression Biomarker
By Jerry Helzner, contributing editor
Study: Repeat SLT proves effective for OAG
By Jerry Helzner, contributing editor
Survey Identifies Resistance to First-Line SLT
By Jerry Helzner, contributing editor
Departments
From the Editor: One Small Step for Lasers
New SLT data could change the glaucoma treatment paradigm.
By Nathan Radcliffe, MD
Dogma vs Data: Delivery Methods and Concentration of Mitomycin C in Filtration Surgery
What you learned in training may no longer be true.
By Jacob W. Brubaker, MD
Product Spotlight: Portable Device Makes Visual Field Testing Accessible to Anyone
A telemedicine component allows physicians to access captured data.
By Karen Appold, contributing writer